Evidence map›Paper›PMID 19372372›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Site-specific integration of adeno-associated virus involves partial duplication of the target locus.

Els Henckaerts, Nathalie Dutheil, Nadja Zeltner, Steven Kattman, Erik Kohlbrenner, Peter Ward, Nathalie Clément, Patricia Rebollo, Marion Kennedy, Gordon M Keller and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Article
  3. Gene editing enables non-invasiveMolecular therapy. Methods & clinical development · 2025
    Article
  4. Article
  5. Article
  6. Clinical applications of gene therapy for rare diseases: A review.International journal of experimental pathology · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Optogenetic Approaches to Target Specific Neural Circuits in Post-stroke Recovery.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2016
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Els HenckaertsDepartment of Infectious Diseases, King's College London School of Medicine, London SE1 9RT, United Kingdom.
Nathalie Dutheil
Nadja Zeltner
Steven Kattman
Erik Kohlbrenner
Peter Ward
Nathalie Clément
Patricia Rebollo
Marion Kennedy
Gordon M Keller
R Michael Linden

Funding

Viral Vector, Cell Line, Tissue & Mouse Model Production, Validation & ProcessingP01DK062345 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI WILSON, PATRICIA D. · 2003 to 2007
$6.7M
GROWTH, DIFFERENTIATION AND GENETIC ALTERATION OF HUMAN ES CELLSP20GM075019 · NIGMS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI KELLER, GORDON · 2005 to 2007
$2.8M
AAV-mediated targeted DNA integration in mouse ES cellsR01GM071023 · NIGMS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI LINDEN, RALPH MICHAEL · 2005 to 2008
$1.2M
NHLBI NIH HHS F32-HL678112NIDDK NIH HHS DK062345NIDDK NIH HHS P01 DK062345NIGMS NIH HHS GM071023NIGMS NIH HHS GM075019NIGMS NIH HHS P20 GM075019NIGMS NIH HHS R01 GM071023
6 · The paper itself

Abstract

A variety of viruses establish latency by integrating their genome into the host genome. The integration event generally occurs in a nonspecific manner, precluding the prediction of functional consequences from resulting disruptions of affected host genes. The nonpathogenic adeno-associated virus (AAV) is unique in its ability to stably integrate in a site-specific manner into the human MBS85 gene. To gain a better understanding of the integration mechanism and the consequences of MBS85 disruption, we analyzed the molecular structure of AAV integrants in various latently infected human cell lines. Our study led to the observation that AAV integration causes an extensive but partial duplication of the target gene. Intriguingly, the molecular organization of the integrant leaves the possibility that a functional copy of the disrupted target gene could potentially be preserved despite the resulting rearrangements. A latently infected, Mbs85-targeted mouse ES cell line was generated to study the functional consequences of the observed duplication-based integration mechanism. AAV-modified ES cell lines continued to self-renew, maintained their multilineage differentiation potential and contributed successfully to mouse development when injected into blastocysts. Thus, our study reveals a viral strategy for targeted genome addition with the apparent absence of functional consequences.

Indexed as

Virus IntegrationVirus LatencyAnimalsCell LineDependovirusEmbryonic Stem CellsGene ExpressionGene TargetingHumansMiceProtein Phosphatase 1ProvirusesMbs85 protein, mousePPP1R12C protein, humanProtein Phosphatase 1

Identifiers

PMID19372372
PMCPMC2669786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.